Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
Talseth-Palmer BA, Wijnen JT, Brenne IS, Jagmohan-Changur S, Barker D, Ashton KA, Tops CM, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G; Dutch Cancer Genetics Group; Spigelman A, Møller P, Morreau HM, Van Wezel T, Lubinski J, Vasen HF, Scott RJ.
Talseth-Palmer BA, et al. Among authors: spigelman a.
Int J Cancer. 2013 Apr 1;132(7):1556-64. doi: 10.1002/ijc.27843. Epub 2012 Oct 11.
Int J Cancer. 2013.
PMID: 22987364